SCHEMBL30803032

SCHEMBL30803032

O=C(OCc1cccc(O)c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1O

nearest known ligand 0.53

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SLC28A3 Q9HAS3 4/20 0.53
▸ SLC5A1 P13866 4/20 0.49
▸ SLC5A2 P31639 4/20 0.49
▸ HIF1A Q16665 1/20 0.47
▸ TYR P14679 2/20 0.46
▸ EPHX2 P34913 2/20 0.44
▸ TYMP P19971 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30803061 0.89 SLC28A3 (0.57) SLC28A3SLC5A1SLC5A2HIF1ATYR
SCHEMBL4636160 0.82 SLC28A3 (0.58) SLC28A3SLC5A1SLC5A2HIF1ATYR
Idesin SCHEMBL29441214 0.81 SLC28A3 (0.58) SLC28A3SLC5A1SLC5A2HIF1ATYR
Idesin SCHEMBL22807218 0.81 SLC28A3 (0.58) SLC28A3SLC5A1SLC5A2HIF1ATYR
SCHEMBL4635870 0.80 SLC28A3 (0.56) SLC28A3SLC5A1SLC5A2HIF1ATYR
SCHEMBL4635305 0.80 SLC28A3 (0.61) SLC28A3SLC5A1SLC5A2HIF1ATYR
SCHEMBL4636191 0.79 SLC28A3 (0.61) SLC28A3SLC5A1SLC5A2HIF1AEPHX2
SCHEMBL7184467 0.79 SLC28A3 (0.51) SLC28A3SLC5A1SLC5A2HIF1ATYR
SCHEMBL4652290 0.78 SLC28A3 (0.55) SLC28A3SLC5A1SLC5A2HIF1ATYR
SCHEMBL7193412 0.78 MAOB (0.54) SLC28A3SLC5A1SLC5A2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024033288-A1 SALICIN DERIVATIVES AS INHIBITORS OF SGLT2 Société des Produits Nestlé S.A. (CH) 2024-02-15 — — WO claimed
WO-2024033288-A1 SALICIN DERIVATIVES AS INHIBITORS OF SGLT2 Société des Produits Nestlé S.A. (CH) 2024-02-15 — — WO disclosed
Send feedback